4893 items matching your search terms.

The LEAD study protocol: a mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgrounds

Mazza, D. Lin, X. Walter, F. M. Young, J. M. Barnes, D. J. Mitchell, P. Brijnath, B. Martin, A. Emery, J. D.
BMC CANCER, 2018     DOI:10.1186/s12885-018-4671-4

Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: A randomised controlled trial protocol

McAuley, S. A. de Bock, M. I. Sundararajan, V. Lee, M. H. Paldus, B. Ambler, G. R. Bach, L. A. Burt, M. G. Cameron, F. J. Clarke, P. M. Cohen, N. D. Colman, P. G. Davis, E. A. Fairchild, J. M. Hendrieckx, C. Holmes-Walker, D. J. Horsburgh, J. C. Jenkins, A. J. Kaye, J. Keech, A. C. King, B. R. Kumareswaran, K. MacIsaac, R. J. McCallum, R. W. Nicholas, J. A. Sims, C. Speight, J. Stranks, S. N. Trawley, S. Ward, G. M. Vogrin, S. Jones, T. W. O'Neal, D. N.
BMJ OPEN, 2018     DOI:10.1136/bmjopen-2017-020274

Outcomes for women with gestational diabetes treated with metformin: A retrospective, case-control study

McGrath, R. T. Glastras, S. J. Scott, E. S. Hocking, S. L. Fulcher, G. R.
J CLIN MED, 2018     DOI:10.3390/jcm7030050

Biosimilarity and interchangeability: Principles and evidence: A systematic review

McKinnon, R. A. Cook, M. Liauw, W. Marabani, M. Marschner, I. C. Packer, N. H. Prins, J. B.
BIODRUGS, 2018     DOI:10.1007/s40259-017-0256-z

The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training

Mercieca-Bebber, R. Calvert, M. Kyte, D. Stockler, M. King, M. T.
CONTEMP CLIN TRIALS COMMUN, 2018     DOI:10.1016/j.conctc.2017.11.009

The importance of patient-reported outcomes in clinical trials and strategies for future optimization

Mercieca-Bebber, R. King, M. T. Calvert, M. J. Stockler, M. R. Friedlander, M.
PATIENT RELAT OUTCOME MEAS, 2018     DOI:10.2147/PROM.S156279

Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR)

Mercieca-Bebber, R. Williams, D. Tait, M. A. Roydhouse, J. Busija, L. Sundaram, C. S. Wilson, M. Langford, A. Rutherford, C. Roberts, N. King, M. Vodicka, E. Devine, B. International Society for Quality of Life, Research
QUALITY OF LIFE RESEARCH, 2018     DOI:10.1007/s11136-018-1921-5

Correction to: Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR)

Mercieca-Bebber, R. Williams, D. Tait, M. A. Roydhouse, J. Busija, L. Sundaram, C. S. Wilson, M. Langford, A. Rutherford, C. Roberts, N. King, M. Vodicka, E. Devine, B. International Society for Quality of Life, Research
QUALITY OF LIFE RESEARCH, 2018     DOI:10.1007/s11136-018-1934-0

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: A study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

Mersiades, A. J. Tognela, A. Haber, P. S. Stockler, M. Lintzeris, N. Simes, J. McGregor, I. Olver, I. Allsop, D. J. Gedye, C. Kirby, A. C. Morton, R. L. Fox, P. Clarke, S. Briscoe, K. Aghmesheh, M. Wong, N. Walsh, A. Hahn, C. Grimison, P.
BMJ OPEN, 2018     DOI:10.1136/bmjopen-2017-020745

Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM system in a quaternary oncology centre

Moloney, M. Faulkner, D. Link, E. Rischin, D. Solomon, B. Lim, A. M. Zalcberg, J. R. Jefford, M. Michael, M.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018     DOI:10.1007/s00280-018-3679-4

Practical guide for identifying unmet clinical needs for biomarkers

Monaghan, P. J. Robinson, S. Rajdl, D. Bossuyt, P. M. M. Sandberg, S. St John, A. O'Kane, M. Lennartz, L. Roddiger, R. Lord, S. J. Cobbaert, C. M. Horvath, A. R.

The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: Molecular analysis of the AGITG MAX clinical trial

Mooi, J. K. Wirapati, P. Asher, R. Lee, C. K. Savas, P. Price, T. J. Townsend, A. Hardingham, J. Buchanan, D. Williams, D. Tejpar, S. Mariadason, J. M. Tebbutt, N. C.
ANNALS OF ONCOLOGY, 2018     DOI:10.1093/annonc/mdy410

Impact of CKD on household income

Morton, R. L. Schlackow, I. Gray, A. Emberson, J. Herrington, W. Staplin, N. Reith, C. Howard, K. Landray, M. J. Cass, A. Baigent, C. Mihaylova, B. Sharp Collaborative Group
KIDNEY INT REP, 2018     DOI:10.1016/j.ekir.2017.12.008

How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists

Moth, E. B. Kiely, B. E. Naganathan, V. Martin, A. Blinman, P.
SUPPORTIVE CARE IN CANCER, 2018     DOI:10.1007/s00520-017-3843-0

Two-stage osseointegrated reconstruction of post-traumatic unilateral transfemoral amputees

Muderis, M. A. Lu, W. Glatt, V. Tetsworth, K.
MILITARY MEDICINE, 2018     DOI:10.1093/milmed/usx185